Join the Respiratory Syncytial Virus group to help and get support from people like you.
Respiratory Syncytial Virus News (Page 4)
Related terms: Bronchiolitis, RSV
How Common Are Co-Infections With COVID, Flu, RSV?
TUESDAY, July 25, 2023 – Results from more than 26,000 respiratory tests in late 2022 found simultaneous infections with COVID-19, influenza or respiratory syncytial virus (RSV) in more than 1% of...
FDA Approves Beyfortus (nirsevimab) for the Prevention of RSV Lower Respiratory Tract Disease in Infants
July 17, 2023 – AstraZeneca and Sanofi’s Beyfortus (nirsevimab) has been approved in the US for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in newborns ...
FDA Approves New Drug, Beyfortus, to Protect Against RSV in Infants
MONDAY, July 17, 2023 (HealthDay Now) – Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of...
Indigenous Children Continue to Experience High Rates of RSV
FRIDAY, July 14, 2023 – American Indian/Alaska Native (AI/AN) children experience high rates of respiratory syncytial virus (RSV)-associated acute respiratory illness (ARI) hospitalization,...
FDA Approves Abrysvo (respiratory syncytial virus vaccine) for the Prevention of Respiratory Syncytial Virus (RSV) in Older Adults
NEW YORK--(BUSINESS WIRE) May 31, 2023 – Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Abrysvo™ (Respiratory Syncytial Virus Vaccine), the c...
Ask a question
To post your own question to this support group, sign in or create an account.